Competitively Low Prices by B. Braun and CareFusion Driving

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Competitively Low Prices by B. Braun and CareFusion Driving European Intravenous Set Market

VANCOUVER, BC, June 4, 2015 (GLOBE NEWSWIRE) -- via PRWEB - According to a recently published report by iData Research ( http://www.idataresearch.com ), growth of the European total intravenous (IV) set market is solely driven by a slight increase in unit sales as the average selling price (ASP) of all device types has been decreasing due to fierce competition and sluggish economic conditions. This market includes primary (dedicated and non-dedicated) and secondary IV sets as well as IV extension sets.

"The increased occurrence of diseases that demand infusion therapy will lead to an increase in the utilization of installed pumps before promoting an increase in unit sales for capital-intensive devices," explains Dr. Kamran Zamanian, CEO of iData. "However, unit sales for secondary IV sets are growing significantly slower than sales of primary IV sets as a result of safety concerns regarding the occurrence of medication error."

Unit sales of primary IV sets are mainly driven by the increasing age of the European population and corresponding growth of the patient pool. Overall market growth has been influenced by strong unit sales growth and a high ASP of primary IV sets dedicated to electronic ambulatory pumps. The growth of secondary IV sets is driven by the increasing number of chemotherapy infusions taking place in hospitals. IV extension sets, used to add length to access IV ports are seeing the highest increases in their use in neonatal intensive care units (NICUs).

Other key findings from the 2015 iData Research report series entitled Europe Markets for Infusion Therapy Devices :

DEHP Recommendations

Regulating agencies have issued warnings about the potential dangers of constructing IV sets and their accessories out of plastics containing di-2-ethylhexyl phthalate (DEHP). Because of these concerns, the European Commission recommends that manufacturers label their devices as containing DEHP, or consider replacing these devices with non-DEHP alternatives. Newer, non-DEHP tubing sets are sold at a higher price than their conventional counterparts, which is driving the IV set market.

Leading Competitors

B. Braun is the leading competitor in the European IV set market with over 30% market share. They have a strong presence in the large volume infusion pump markets in Europe, and because the IV sets used with large volume pumps are dedicated, the company derives a great part of its IV set unit sales from the installed base of these pumps.

Other notable competitors in intravenous set market include CareFusion, Fresenius Kabi, Codan, Hospira, Baxter International, Becton Dickinson, Doran International, ICU Medical, Smiths Medical, and Vygon among others.

For Further Information

More on the intravenous set market in Europe can be found in the report published by iData entitled Europe Markets for Infusion Therapy Devices . This report also covers European market segments for infusion pumps, intravenous sets, and needleless connectors.

The iData series on the market for infusion therapy devices covers the U.S., Japan, South Korea, Australia, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment.

To find out more about European intravenous set market data or procedure data, register online or email us at info@idataresearch.net for a Europe Markets for Infusion Therapy Devices report brochure and synopsis.

About Procedure Tracker

Additional procedure number data is available from iData's Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About iData Research

iData Research ( http://www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology, and more.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/06/prweb12766788.htm

iData Research Marvin Cidamon +1 (604) 266-6933 Ext: 205

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 89

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Banks Face a Choice: Retreat or Fund Climate Resilience

Updated Category News Views 93

A flooded field can turn a prudent loan book into a social retreat overnight. That is the uncomfortable nerve in the Global Alliance for Banking on Values paper unveiled at COP31 in Antalya on November 19, 2026. Banks have become very practiced at mapping physical climate exposure, raising prices, tightening standards and stepping away. Fine, risk discipline matters. But...

Continue Reading
Harbour BioMed's LET003 Gets China's IND Green Light

Updated Category News Views 84

Muscle loss has become the awkward fact sitting beside every blockbuster obesity headline. Harbour BioMed's Nov. 18 announcement that China's National Medical Products Administration accepted its IND application for LET003 matters because the company is aiming directly at that problem: losing fat without giving away too much lean mass along the way. Acceptance Opens a...

Continue Reading
Kuaishou’s AI Push Meets a Brutal Earnings Reality

Updated Category News Views 91

Kuaishou just put a very expensive wrinkle in its AI story. The third-quarter figures are not a minor wobble: revenue dropped 11.1% year over year to RMB31.6 billion, gross margin slid from 54.7% to 48.2%, and the company swung from a RMB4.5 billion profit to a RMB959 million loss. For holders of 01024, that is the sort of earnings release that demands less daydreaming...

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 75

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
Northstar's December Test: Metrics Over More Promises

Updated Category News Views 11

A shingle recycler earns its stripes when the machinery behaves, not when the slide deck does. Northstar Clean Technologies is putting Empower Calgary under a brighter light on December 1, pairing its third-quarter 2026 results with a comprehensive production update and a new set of operating metrics. For shareholders, especially those following OTCQB:ROOOF, this is the...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 35

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 72

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading

Top 5 Most Recently Viewed Articles

MediPharm Labs: Strategic Steps for Enhanced Shareholder Value

Updated Category News Views 141

MediPharm Labs Announces Proxy Materials for Shareholder Meetings Toronto - MediPharm Labs Corp. (TSX: LABS) has filed comprehensive Management Information Circulars and proxy materials ahead of its upcoming Annual and Special Meeting. This meeting, pivotal for the future direction of the company, is set for June 16. Shareholders can expect to receive these materials...

Continue Reading
PRM Revitalizes Its Online Presence with Stylish Relaunch

Updated Category News Views 215

PRM Elevates Your Style with an Online Revamp In an exciting development for fashion enthusiasts, PRM, a trendsetting brand where luxury meets urban flair, has unveiled a newly revamped online store. This relaunch marks a significant transformation spearheaded with the expert assistance from industry professionals, aiming to elevate its presence in the European fashion...

Continue Reading
Why Companies Choose Altcoins Like ETH, SOL, and XRP Over Bitcoin

Updated Category News Views 188

Why Companies Are Opting for Altcoins in Their Treasury Strategies In recent times, publicly traded companies have increasingly embraced a wider array of cryptocurrencies beyond Bitcoin. Names like Ethereum, Solana, XRP, and Binance Coin are becoming commonplace in corporate treasuries. This trend reflects a significant shift in how businesses perceive and integrate these...

Continue Reading
Epson Launches Arm-Compatible Drivers for Advanced Scanning Solutions

Updated Category News Views 346

Epson's Commitment to Innovation in Scanning Technology Epson America, the top-selling scanner brand in the U.S., is proud to unveil Arm-compatible drivers for Windows in its extensive lineup of scanners. This groundbreaking step positions Epson as a leader in the scanning technology space, tailored for industries such as healthcare, finance, and enterprise solutions....

Continue Reading
Harnessing AI for Transformation: A Framework for Organizations

Updated Category News Views 240

Harnessing AI for Transformation: A Comprehensive Framework Artificial intelligence (AI) stands as one of the most revolutionary technologies in today’s world, yet many organizations grapple with moving from mere experiments to having a concrete enterprise strategy. A leading research and advisory firm has released a blueprint aimed at guiding both IT and business...

Continue Reading